Follicular Lymphoma | Tumor

Moving Forward After Follicular Lymphoma With a New Companion

October 28th 2025, 4:00pm

Article

I share how my dog helped me through treatment during the pandemic and how adopting a new one reminds me to keep living and planning for a future beyond cancer.

Facing Mortality After Cancer, and Choosing to Live Fully

October 20th 2025, 1:00pm

Article

After her follicular lymphoma diagnosis, Karen Cohn reflects on how cancer reshaped her view of mortality and her choice to keep living fully.

My New Normal After Follicular Lymphoma

October 15th 2025, 5:00pm

Article

After treatment for follicular lymphoma, I reflect on how cancer, retirement, and loss reshaped my sense of normal and what life looks like now.

Challenging Assumptions About Cancer and Its Treatments

September 10th 2025, 9:00pm

Article

Living with follicular lymphoma, I’ve learned many assumptions about cancer, remission and treatment side effects don’t reflect the reality I face.

Epkinly Combo Reduces Risk of Progression or Death in Follicular Lymphoma

August 8th 2025, 3:00pm

Article

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

What’s in a Name? How I Chose ‘Person’ Over ‘Survivor’ After Cancer

July 17th 2025, 9:00pm

Article

When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I am.

Lingering Stress After Follicular Lymphoma Remission is a Challenge

April 30th 2025, 5:06pm

Article

Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue to weigh heavily on me.

Remission is Not a Cure for Follicular Lymphoma, or Any Cancer

April 22nd 2025, 4:54pm

Article

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

The Unseen Long-Term Effects After Follicular Lymphoma Treatment

March 21st 2025, 5:00pm

Article

Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system impacts and lasting social effects.

Expert Explains the Side Effects of Ordspono in R/R Follicular Lymphoma

March 14th 2025, 4:00pm

Video

Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.